Xponential Agrees to Acquire Lindora

Xponential Agrees to Acquire Lindora and Further Solifies Holistic Approach to Health and Wellness

Lindora operates 31 clinics offering the latest innovations in weight loss medications, hormone replacement therapy and IV hydration

IRVINE, Calif.--(BUSINESS WIRE)-- Xponential Fitness, Inc. (NYSE: XPOF) (”Xponential” or “the Company”), the largest global franchisor of health and wellness brands, today announced that it has agreed to acquire Lindora, a leading metabolic health brand. Under the terms of the transaction, the 31 existing Lindora clinics will become Xponential franchise locations. Xponential will acquire all of the intellectual property of Lindora and plans to franchise the brand nationally and globally. Given the strong cashflow of the existing Lindora locations, the acquisition is anticipated to be immediately accretive on both an AUV1 and an Adjusted EBITDA2 basis.

“This acquisition further solidifies Xponential’s leadership in identifying and incorporating the latest innovations in health and wellness,” said Anthony Geisler, CEO of Xponential. “We have long admired Lindora’s integrated approach to metabolic health, effectively combining behavioral approaches with the most recent medical breakthroughs, from weight loss medications to hormone replacement therapy and IV hydration. Lindora complements our existing brands and will help us deliver on consumers’ increasing demand for a holistic approach to health. Lindora is led by a veteran team, and we are looking forward to partnering with them to address some of the most critical and widespread health challenges facing the U.S. and beyond.”

Founded in 1971 in Southern California, Lindora is a leading provider of medically guided wellness and metabolic health solutions. For over 50 years, Lindora has helped tens of thousands of people live healthier lives through its suite of services that support metabolic health, including weight management programs that incorporate nutrition, lifestyle, and the latest innovations in weight loss medications; IV hydration; hormone replacement therapy; and other services. The global weight loss and weight management industry had a market size of over $224 billion in 2021 and is expected to surpass $400 billion by 2030.

“We are thrilled to join the Xponential family of brands,” said Colleen Lewis, CEO of Lindora. “Xponential’s proven model growing and scaling brands makes them the ideal partner as Lindora enters its next phase of growth. This partnership will allow Lindora to become one of the first national brands in medical metabolic management, and we are energized to share what has been effective in delivering outstanding outcomes for our valued clients with people on a global scale.”

The transaction is expected to close in early 2024.

Read the full announcement here.